What is the potential of TOR inhibition for cancer therapy?

Mathematical modelling can be used in cancer therapy

Recombination can drive tumourogenesis

The role of the PI3K and TOR pathways in cancer

Molecular genetics of testicular cancer: What does the clinician need to know?

Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma

Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours

Global cancer partnership

Interrupting breast cancer treatment for young women who desire pregnancy

No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen

No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen

Denosumab improves disease-free survival for postmenopausal patients with HR-positive breast cancer